<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The mechanisms of MHC allele associations with <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) and its <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> subtype (AA/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) remain unclear </plain></SENT>
<SENT sid="1" pm="."><plain>It might be dependent on MHC molecule functional properties, such as a scope and frequency of antigen sampling and presentation </plain></SENT>
<SENT sid="2" pm="."><plain>For documented <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-associated MHC alleles we analyzed current reference databases on MHC molecule-eluted <z:chebi fb="7" ids="16670">peptide</z:chebi> presentation repertoires and searched for a range of presented <z:chebi fb="7" ids="16670">peptides</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>MHC class II expression was measured on CD34+ cells and appeared to be increased in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>Two class I alleles (HLA-A*24:02 and B*18:01) have been previously confirmed to associate with protection and increased risk of AA/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Their product molecules presented immunodominant <z:chebi fb="0" ids="53000">epitopes</z:chebi> derived from proapoptotic (serine/threonine-protein phosphatase) and antiapoptotic (phospholipase D), respectively, intracellular enzymes dependent on <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi> (PI) content </plain></SENT>
<SENT sid="6" pm="."><plain>For total <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and non-aplastic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> (n/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) subtype-associated DRB1*15:01 and DRB1*04:01 class II molecules presentation of exceptionally broad arrays of their own <z:chebi fb="7" ids="16670">peptide</z:chebi> fragments has been found </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that self antigen <z:chebi fb="7" ids="16670">peptides</z:chebi> presented with high frequency in the context of MHC molecules of increased expression may be involved in the immune recognition and the regulation of <z:chebi fb="15" ids="50443">HSC</z:chebi> in the periphery </plain></SENT>
<SENT sid="8" pm="."><plain>The block in the <z:mpath ids='MPATH_458'>normal</z:mpath> plasma membrane PI production due to the PIG-A mutation can help explain the differences in the activation of intracellular regulatory pathways observed between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="15" ids="50443">HSC</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>This is evident in the variation in MHC association patterns and <z:chebi fb="7" ids="16670">peptide</z:chebi> presentation repertoires between these two groups of patients </plain></SENT>
</text></document>